Product Description
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Large Molecule
Route of Administration: Subcutaneous, Topical, Transdermal
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Malaysia | United Kingdom
Approved Indications: None
Known Adverse Events: None
Company: Perron Institute for Neurological and Translational Science
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|